Assessing Metabolic health in obesity using the eoss
Medical guidelines apply broadly to individuals with obesity. Using provincial records linking maternal and newborn outcomes, this study stratified 317,958 pregnancies between 2008-2018 births in British Columbia by WHO body mass index categories, then further stratified using a perinatal adaptation of the Edmonton Obesity Staging System (EOSS) which categorizes obesity using related co-morbid disease. EOSS stage 0 has no co-morbid disease, stage 1 has subclinical symptoms such as hyperlipidemia. Stage 2 includes obesity-related co-morbidities such as hypertension or diabetes. Stage 3 has obesity-related end organ disease exemplified by heart disease. EOSS stage 4 has severe end organ disease such as renal failure. The attached poster shows results.